Leah Schmidt

Leah Schmidt is a Principal Scientist at Pfizer, specializing in cancer immunology. They have extensive experience in engineered adoptive T cell therapy, natural killer cell responses against solid tumors, and the immunological effects of cancer therapies within drug discovery. Leah previously held roles as a Senior Scientist in ADC Immunology at both Pfizer and Seagen, and contributed as a Postdoctoral Researcher at the University of Washington's Phil Greenberg Lab. They earned a PhD in Cancer Immunology from the Massachusetts Institute of Technology, following a Bachelor of Science in Biochemistry from McMaster University.